Search Results
You are looking at 11 - 16 of 16 items for
- Author: Xin Li x
- Refine by access: All content x
Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Environmental Science and Public Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, People's Republic of China
Search for other papers by Shibin Ding in
Google Scholar
PubMed
Search for other papers by Ying Fan in
Google Scholar
PubMed
Search for other papers by Nana Zhao in
Google Scholar
PubMed
Search for other papers by Huiqin Yang in
Google Scholar
PubMed
Search for other papers by Xiaolei Ye in
Google Scholar
PubMed
Search for other papers by Dongliang He in
Google Scholar
PubMed
Search for other papers by Xin Jin in
Google Scholar
PubMed
Search for other papers by Jian Liu in
Google Scholar
PubMed
Search for other papers by Chong Tian in
Google Scholar
PubMed
Search for other papers by Hongyu Li in
Google Scholar
PubMed
Search for other papers by Shunqing Xu in
Google Scholar
PubMed
Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Environmental Science and Public Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, People's Republic of China
Search for other papers by Chenjiang Ying in
Google Scholar
PubMed
Epidemiological findings on the association between bisphenol A (BPA, 2,2-bis-(4-hydroxyphenyl)propane) exposure and type 2 diabetes mellitus (T2DM) are paradoxical. In animal studies, BPA has been shown to disrupt pancreatic function and blood glucose homeostasis even at a reference ‘safe’ level during perinatal period. In this study, we explored the effects of long-term paternal exposure to a ‘safe’ level of BPA on parents themselves and their offspring. Adult male genitor rats fed with either standard chow diet (STD) or high-fat diet (HFD) were treated respectively with either vehicle or BPA (50 μg/kg per day) for 35 weeks. The male rats treated with vehicle or BPA for 21 weeks were then used as sires, and the adult female rats were fed with STD during the gestation and lactation. Offspring rats were weaned on postnatal day 21 and fed with STD in later life. Metabolic parameters were recorded on the adult male rats and their adult offspring. BPA exposure disrupted glucose homeostasis and pancreatic function, and HFD aggravated these adverse effects. However, BPA exposure did not alter body weight, body fat percentage, or serum lipid. In addition, the paternal BPA exposure did not cause adverse reproductive consequence or metabolic disorder in the adult offspring. Our findings indicate that chronic exposure to a predicted ‘safe’ dose of BPA contributes to glucose metabolic disorders, and that HFD aggravates these adverse effects in paternal rats.
Search for other papers by Zhe-Zhen Liao in
Google Scholar
PubMed
Search for other papers by Xiao-Yan Qi in
Google Scholar
PubMed
Search for other papers by Ya-Di Wang in
Google Scholar
PubMed
Search for other papers by Jiao-Yang Li in
Google Scholar
PubMed
Search for other papers by Qian-Qian Gu in
Google Scholar
PubMed
Search for other papers by Can Hu in
Google Scholar
PubMed
Search for other papers by Yin Hu in
Google Scholar
PubMed
Search for other papers by Heng Sun in
Google Scholar
PubMed
Search for other papers by Li Ran in
Google Scholar
PubMed
Search for other papers by Jing Yang in
Google Scholar
PubMed
Search for other papers by Jiang-Hua Liu in
Google Scholar
PubMed
Search for other papers by Xin-Hua Xiao in
Google Scholar
PubMed
Remodeling of energy-storing white fat into energy-consuming beige fat has led to a promising new approach to alleviate adiposity. Several studies have shown adipokines can induce white adipose tissue (WAT) beiging through autocrine or paracrine actions. Betatrophin, a novel adipokine, has been linked to energy expenditure and lipolysis but not clearly clarified. Here, we using high-fat diet-induced obesity to determine how betatrophin modulate beiging and adiposity. We found that betatrophin-knockdown mice displayed less white fat mass and decreased plasma TG and NEFA levels. Consistently, inhibition of betatrophin leads to the phenotype change of adipocytes characterized by increased mitochondria contents, beige adipocytes and mitochondria biogenesis-specific markers both in vivo and in vitro. Of note, blocking AMP-activated protein kinase (AMPK) signaling pathway is able to abolish enhanced beige-like characteristics in betatrophin-knockdown adipocytes. Collectively, downregulation of betatrophin induces beiging in white adipocytes through activation of AMPK signaling pathway. These processes suggest betatrophin as a latent therapeutic target for obesity.
Transgenic Research Center, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Mingjiao Zhang in
Google Scholar
PubMed
Search for other papers by Salah Adlat in
Google Scholar
PubMed
Search for other papers by Xiaodan Lu in
Google Scholar
PubMed
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Honghong Jin in
Google Scholar
PubMed
Search for other papers by Chenhao Wang in
Google Scholar
PubMed
Search for other papers by Zin Mar Oo in
Google Scholar
PubMed
Search for other papers by Farooq Hayel in
Google Scholar
PubMed
Search for other papers by Quangang Chen in
Google Scholar
PubMed
Search for other papers by Xufeng Han in
Google Scholar
PubMed
Search for other papers by Renjin Chen in
Google Scholar
PubMed
Search for other papers by Xuechao Feng in
Google Scholar
PubMed
Search for other papers by Luqing Zhang in
Google Scholar
PubMed
Search for other papers by Yaowu Zheng in
Google Scholar
PubMed
Obesity is caused by imbalanced energy intake and expenditure. Excessive energy intake and storage in adipose tissues are associated with many diseases. Several studies have demonstrated that vascular growth endothelial factor B (VEGFB) deficiency induces obese phenotypes. However, the roles of VEGFB isoforms VEGFB167 and VEGFB186 in adipose tissue development and function are still not clear. In this study, genetic mouse models of adipose-specific VEGFB167 and VEGFB186 overexpression (aP2-Vegfb167 tg/+ and aP2-Vegfb186 tg/+ ) were generated and their biologic roles were investigated. On regular chow, adipose-specific VEGFB186 is negatively associated with white adipose tissues (WATs) and positively regulates brown adipose tissues (BATs). VEGFB186 upregulates energy metabolism and metabolism-associated genes. In contrast, VEGFB167 has a nominal role in adipose development and function. On high-fat diet, VEGFB186 expression can reverse the phenotypes of VEGFB deletion. VEGFB186 overexpression upregulates BAT-associated genes and downregulates WAT-associated genes. VEGFB186 and VEGFB167 have very distinct roles in the regulation of adipose development and energy metabolism. As a key regulator of adipose tissue development and energy metabolism, VEGFB186 may be a target for obesity prevention and treatment.
Biotecan Medical Diagnostics Co., Ltd, Zhangjiang Center for Translational Medicine, Shanghai, China
Search for other papers by Wang-Yang Xu in
Google Scholar
PubMed
Search for other papers by Yan Shen in
Google Scholar
PubMed
Search for other papers by Houbao Zhu in
Google Scholar
PubMed
Search for other papers by Junhui Gao in
Google Scholar
PubMed
Search for other papers by Chen Zhang in
Google Scholar
PubMed
Search for other papers by Lingyun Tang in
Google Scholar
PubMed
Search for other papers by Shun-Yuan Lu in
Google Scholar
PubMed
Search for other papers by Chun-Ling Shen in
Google Scholar
PubMed
Search for other papers by Hong-Xin Zhang in
Google Scholar
PubMed
Search for other papers by Ziwei Li in
Google Scholar
PubMed
Search for other papers by Peng Meng in
Google Scholar
PubMed
Search for other papers by Ying-Han Wan in
Google Scholar
PubMed
Search for other papers by Jian Fei in
Google Scholar
PubMed
Shanghai Research Center for Model Organisms, Shanghai, China
Model Organism Division, E-Institutes of Shanghai Universities, Shanghai, China
Search for other papers by Zhu-Gang Wang in
Google Scholar
PubMed
Obesity and type 2 diabetes (T2D) are both complicated endocrine disorders resulting from an interaction between multiple predisposing genes and environmental triggers, while diet and exercise have key influence on metabolic disorders. Previous reports demonstrated that 2-aminoadipic acid (2-AAA), an intermediate metabolite of lysine metabolism, could modulate insulin secretion and predict T2D, suggesting the role of 2-AAA in glycolipid metabolism. Here, we showed that treatment of diet-induced obesity (DIO) mice with 2-AAA significantly reduced body weight, decreased fat accumulation and lowered fasting glucose. Furthermore, Dhtkd1−/− mice, in which the substrate of DHTKD1 2-AAA increased to a significant high level, were resistant to DIO and obesity-related insulin resistance. Further study showed that 2-AAA induced higher energy expenditure due to increased adipocyte thermogenesis via upregulating PGC1α and UCP1 mediated by β3AR activation, and stimulated lipolysis depending on enhanced expression of hormone-sensitive lipase (HSL) through activating β3AR signaling. Moreover, 2-AAA could alleviate the diabetic symptoms of db/db mice. Our data showed that 2-AAA played an important role in regulating glycolipid metabolism independent of diet and exercise, implying that improving the level of 2-AAA in vivo could be developed as a strategy in the treatment of obesity or diabetes.
Search for other papers by Yuehui Zhang in
Google Scholar
PubMed
Department of Traditional Chinese Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Search for other papers by Min Hu in
Google Scholar
PubMed
Search for other papers by Wenyan Jia in
Google Scholar
PubMed
Search for other papers by Guoqi Liu in
Google Scholar
PubMed
Search for other papers by Jiao Zhang in
Google Scholar
PubMed
Search for other papers by Bing Wang in
Google Scholar
PubMed
Department of Traditional Chinese Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Search for other papers by Juan Li in
Google Scholar
PubMed
Department of Gynecology, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
Search for other papers by Peng Cui in
Google Scholar
PubMed
Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Susanne Lager in
Google Scholar
PubMed
Search for other papers by Amanda Nancy Sferruzzi-Perri in
Google Scholar
PubMed
Search for other papers by Yanhua Han in
Google Scholar
PubMed
Search for other papers by Songjiang Liu in
Google Scholar
PubMed
Search for other papers by Xiaoke Wu in
Google Scholar
PubMed
Search for other papers by Mats Brännström in
Google Scholar
PubMed
Search for other papers by Linus R Shao in
Google Scholar
PubMed
Search for other papers by Håkan Billig in
Google Scholar
PubMed
Women with polycystic ovary syndrome (PCOS) have hyperandrogenism and insulin resistance and a high risk of miscarriage during pregnancy. Similarly, in rats, maternal exposure to 5α-dihydrotestosterone (DHT) and insulin from gestational day 7.5 to 13.5 leads to hyperandrogenism and insulin resistance and subsequently increased fetal loss. A variety of hormonal and metabolic stimuli are able to trigger different types of regulated cell death under physiological and pathological conditions. These include ferroptosis, apoptosis and necroptosis. We hypothesized that, in rats, maternal hyperandrogenism and insulin-resistance-induced fetal loss is mediated, at least in part, by changes in the ferroptosis, apoptosis and necroptosis pathways in the gravid uterus and placenta. Compared with controls, we found that co-exposure to DHT and insulin led to decreased levels of glutathione peroxidase 4 (GPX4) and glutathione, increased glutathione + glutathione disulfide and malondialdehyde, aberrant expression of ferroptosis-associated genes (Acsl4, Tfrc, Slc7a11, and Gclc), increased iron deposition and activated ERK/p38/JNK phosphorylation in the gravid uterus. In addition, we observed shrunken mitochondria with electron-dense cristae, which are key features of ferroptosis-related mitochondrial morphology, as well as increased expression of Dpp4, a mitochondria-encoded gene responsible for ferroptosis induction in the uteri of rats co-exposed to DHT and insulin. However, in the placenta, DHT and insulin exposure only partially altered the expression of ferroptosis-related markers (e.g. region-dependent GPX4, glutathione + glutathione disulfide, malondialdehyde, Gls2 and Slc7a11 mRNAs, and phosphorylated p38 levels). Moreover, we found decreased expression of Dpp4 mRNA and increased expression of Cisd1 mRNA in placentas of rats co-exposed to DHT and insulin. Further, DHT + insulin-exposed pregnant rats exhibited decreased apoptosis in the uterus and increased necroptosis in the placenta. Our findings suggest that maternal hyperandrogenism and insulin resistance causes the activation of ferroptosis in the gravid uterus and placenta, although this is mediated via different mechanisms operating at the molecular and cellular levels. Our data also suggest that apoptosis and necroptosis may play a role in coordinating or compensating for hyperandrogenism and insulin-resistance-induced ferroptosis when the gravid uterus and placenta are dysfunctional.
Search for other papers by Shisan Xu in
Google Scholar
PubMed
Search for other papers by Fangjing Xie in
Google Scholar
PubMed
Search for other papers by Li Tian in
Google Scholar
PubMed
Search for other papers by Samane Fallah in
Google Scholar
PubMed
Search for other papers by Fatemeh Babaei in
Google Scholar
PubMed
Search for other papers by Sinai H C Manno in
Google Scholar
PubMed
Search for other papers by Francis A M Manno III in
Google Scholar
PubMed
Search for other papers by Lina Zhu in
Google Scholar
PubMed
Search for other papers by Kin Fung Wong in
Google Scholar
PubMed
Search for other papers by Yimin Liang in
Google Scholar
PubMed
Search for other papers by Rajkumar Ramalingam in
Google Scholar
PubMed
Search for other papers by Lei Sun in
Google Scholar
PubMed
Search for other papers by Xin Wang in
Google Scholar
PubMed
Search for other papers by Robert Plumb in
Google Scholar
PubMed
Search for other papers by Lee Gethings in
Google Scholar
PubMed
Search for other papers by Yun Wah Lam in
Google Scholar
PubMed
State Key Laboratory of Marine Pollution (SKLMP) at City University of Hong Kong, Hong Kong SAR, People’s Republic of China
Department of Materials Science and Engineering, College of Science and Engineering, City University of Hong Kong, Hong Kong SAR, People’s Republic of China
Search for other papers by Shuk Han Cheng in
Google Scholar
PubMed
Sexual differences have been observed in the onset and prognosis of human cardiovascular diseases, but the underlying mechanisms are not clear. Here, we found that zebrafish heart regeneration is faster in females, can be accelerated by estrogen and is suppressed by the estrogen-antagonist tamoxifen. Injuries to the zebrafish heart, but not other tissues, increased plasma estrogen levels and the expression of estrogen receptors, especially esr2a. The resulting endocrine disruption induces the expression of the female-specific protein vitellogenin in male zebrafish. Transcriptomic analyses suggested heart injuries triggered pronounced immune and inflammatory responses in females. These responses, previously shown to elicit heart regeneration, could be enhanced by estrogen treatment in males and reduced by tamoxifen in females. Furthermore, a prior exposure to estrogen preconditioned the zebrafish heart for an accelerated regeneration. Altogether, this study reveals that heart regeneration is modulated by an estrogen-inducible inflammatory response to cardiac injury. These findings elucidate a previously unknown layer of control in zebrafish heart regeneration and provide a new model system for the study of sexual differences in human cardiac repair.
